Use of carbonic anhydrase inhibitor in the treatment of pancreatitis
- 1 May 1966
- journal article
- research article
- Published by Springer Nature in Digestive Diseases and Sciences
- Vol. 11 (5) , 367-376
- https://doi.org/10.1007/bf02233631
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- The Pathological Physiology of Pancreatic InflammationPublished by American Medical Association (AMA) ,1961
- Depression of pancreatic exocrine secretion with a carbonic anhydrase inhibitorDigestive Diseases and Sciences, 1960
- Physiologic observations upon a partial pancreatic fistula following gastrectomyThe American Journal of Surgery, 1959
- Renal Colic and Anuria from AcetazolamideBMJ, 1958
- Toxicity Due to Acetazolamide (Diamox)Archives of Ophthalmology (1950), 1958
- Retrograde Surgical Drainage of Pancreas for Chronic Relapsing PancreatitisArchives of Surgery, 1958
- ACUTE TRANSIENT MYOPIA ASSOCIATED WITH USE OF ACETAZOLAMIDE (DIAMOX)JAMA, 1957
- Effect of a carbonic anhydrase inhibitor, acetazoleamide, upon gastric secretion in man; report of its use separately and in conjunction with anticholinergic drugs.1955
- AGRANULOCYTOSIS FOLLOWING DIAMOX THERAPYJAMA, 1955
- Inhibition of Pancreatic Secretion by the Carbonic Anhydrase Inhibitor, 2-Acetylamino-l,3,4-Thiadiazole-5-Sulfonamide (Compound No. 6063).Experimental Biology and Medicine, 1952